CVSA Q1 2026 Earnings Strong EPS Surprise Drives Positive Stock Reaction CCLD Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Declines Fate Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Pipeline Development Dermata Therapeutics DRMA Q1 2026 Earnings Narrower Loss Beats Expectations as Pipeline Progress Continues QNRX Q1 2026 Earnings Beats EPS Estimates Despite No Revenue Stock Declines 062 ORC Q1 2026 Earnings Strong EPS Beat Amid Stock Decline